SABS SAB Biotherapeutics, Inc.

NASDAQ

$3.30

SAB Biotherapeutics, Inc. (SABS) Earnings News

Earnings press releases, previews and reviews for SAB Biotherapeutics, Inc. (SABS), newest first. Our most recent is preview: SAB Biotherapeutics Heads Into Q3 With Safeguard Enrollment Clock and Tzield Competition in Focus.

Thursday October 29, 2026 12:01 PM ET

SAB Biotherapeutics Heads Into Q3 With Safeguard Enrollment Clock and Tzield Competition in Focus

Earnings Whispers · Preview

Thursday October 29, 2026 8:30 AM ET

SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET

Thursday August 6, 2026 7:30 AM ET

SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights

Thursday July 30, 2026 8:30 AM ET

SAB BIO to Host Second Quarter 2026 Financial Results Conference Call and Webcast on August 6, 2026, 08:30 AM ET

Tuesday May 12, 2026 7:30 AM ET

SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights